NM_001110792.2:c.1021G>A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_001110792.2(MECP2):c.1021G>A(p.Gly341Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000909 in 1,210,629 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001110792.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MECP2 | NM_001110792.2 | c.1021G>A | p.Gly341Ser | missense_variant | Exon 3 of 3 | ENST00000453960.7 | NP_001104262.1 | |
MECP2 | NM_004992.4 | c.985G>A | p.Gly329Ser | missense_variant | Exon 4 of 4 | ENST00000303391.11 | NP_004983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000453960.7 | c.1021G>A | p.Gly341Ser | missense_variant | Exon 3 of 3 | 1 | NM_001110792.2 | ENSP00000395535.2 | ||
MECP2 | ENST00000303391.11 | c.985G>A | p.Gly329Ser | missense_variant | Exon 4 of 4 | 1 | NM_004992.4 | ENSP00000301948.6 |
Frequencies
GnomAD3 genomes AF: 0.0000267 AC: 3AN: 112373Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34539
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183408Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67864
GnomAD4 exome AF: 0.00000728 AC: 8AN: 1098256Hom.: 0 Cov.: 35 AF XY: 0.0000110 AC XY: 4AN XY: 363610
GnomAD4 genome AF: 0.0000267 AC: 3AN: 112373Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34539
ClinVar
Submissions by phenotype
MECP2-related disorder Uncertain:1
The MECP2 c.985G>A variant is predicted to result in the amino acid substitution p.Gly329Ser. This variant has been reported in one individual with schizophrenia (Supplementary table 4, Piton A et al. 2010. PubMed ID: 20479760). This variant is reported in 0.0052% of alleles in individuals of African descent in gnomAD, including two hemizygous individuals, which is likely too frequent to be a primary cause of disease. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Rett syndrome Benign:1
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria.Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as Benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2). -
not specified Benign:1
- -
Severe neonatal-onset encephalopathy with microcephaly Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at